Find Hydroxytyrosol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 10597-60-1, 3,4-dihydroxyphenylethanol, 2-(3,4-dihydroxyphenyl)ethanol, 4-(2-hydroxyethyl)benzene-1,2-diol, Dopet, 3,4-dihydroxyphenethyl alcohol
Molecular Formula
C8H10O3
Molecular Weight
154.16  g/mol
InChI Key
JUUBCHWRXWPFFH-UHFFFAOYSA-N
FDA UNII
QEU0NE4O90

Hydroxytyrosol
Hydroxytyrosol is a phenolic phytochemical naturally occurring in extra virgin olive oil, with potential antioxidant, anti-inflammatory and cancer preventive activities. Although the mechanisms of action through which hydroxytyrosol exerts its effects have yet to be fully determined, this agent affects the expression of various components of the inflammatory response, possibly through the modulation of the nuclear factor-kappa B (NF-kB) pathway. The effects include the modulation of pro-inflammatory cytokines, such as the inhibition of interleukin-1alpha (IL-1a), IL-1beta, IL-6, IL-12, and tumor necrosis factor-alpha (TNF-a); increased secretion of the anti-inflammatory cytokine IL-10; inhibition of the production of certain chemokines, such as C-X-C motif chemokine ligand 10 (CXCL10/IP-10), C-C motif chemokine ligand 2 (CCL2/MCP-1), and macrophage inflammatory protein-1beta (CCL4/MIP-1b); and inhibition of the expression of the enzymes inducible nitric oxide synthase (iNOS/NOS2) and prostaglandin E2 synthase (PGES), which prevent the production of nitric oxide (NO) and prostaglandin E (PGE2), respectively. In addition, hydroxytyrosol is able to regulate the expression of other genes involved in the regulation of tumor cell proliferation, such as extracellular signal-regulated and cyclin-dependent kinases. Also, hydroxytyrosol scavenges free radicals and prevents oxidative DNA damage. This induces apoptosis and inhibits proliferation in susceptible cancer cells.
1 2D Structure

Hydroxytyrosol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-(2-hydroxyethyl)benzene-1,2-diol
2.1.2 InChI
InChI=1S/C8H10O3/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,9-11H,3-4H2
2.1.3 InChI Key
JUUBCHWRXWPFFH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=C(C=C1CCO)O)O
2.2 Other Identifiers
2.2.1 UNII
QEU0NE4O90
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-(3,4-dihydroxyphenyl)ethanol

2. 3,4-dihydroxyphenylethanol

3. Beta-3,4-dihydroxyphenylethyl Alcohol

4. Dopet

2.3.2 Depositor-Supplied Synonyms

1. 10597-60-1

2. 3,4-dihydroxyphenylethanol

3. 2-(3,4-dihydroxyphenyl)ethanol

4. 4-(2-hydroxyethyl)benzene-1,2-diol

5. Dopet

6. 3,4-dihydroxyphenethyl Alcohol

7. 3-hydroxytyrosol

8. 1,2-benzenediol, 4-(2-hydroxyethyl)-

9. 2-(3,4-dihydroxyphenyl)ethyl Alcohol

10. 3,4-dihydroxyphenethylalcohol

11. 4-(2-hydroxyethyl)-1,2-benzenediol

12. Beta-3,4-dihydroxyphenylethyl Alcohol

13. Dihydroxyphenylethanol

14. Mfcd01320529

15. Qeu0ne4o90

16. Chebi:68889

17. Unii-qeu0ne4o90

18. Dopaol

19. 3,4-dihydroxy-1-benzeneethanol

20. 4-(2-hydroxy-ethyl)-benzene-1,2-diol

21. Hydroxytyrosol [mi]

22. Schembl44363

23. Hydroxytyrosol [inci]

24. 3,4-dhpea

25. Hydroxytyrosol [who-dd]

26. Chembl1950045

27. Ba2774

28. Juubchwrxwpffh-uhfffaoysa-

29. Dtxsid70147451

30. Ba 2774

31. Bcp31094

32. Hy-n0570

33. Zinc2379217

34. 2-(3,4-di-hydroxyphenyl)-ethanol

35. S3826

36. 3-hydroxytyrosol, >=98% (hplc)

37. 3-hydroxytyrosol, Analytical Standard

38. Akos003368868

39. Ac-5308

40. Ccg-266246

41. Db12771

42. As-10017

43. Sy017402

44. Db-008830

45. Am20020163

46. Cs-0009107

47. D2756

48. Ft-0600597

49. Ft-0670206

50. N2302

51. 597d601

52. A801346

53. Q744577

54. Q-100040

55. Brd-k04809113-001-01-7

56. 3,4-dihydroxyphenethyl Alcohol;3,4-dihydroxyphenyl Ethanol

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 154.16 g/mol
Molecular Formula C8H10O3
XLogP3-0.7
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass154.062994177 g/mol
Monoisotopic Mass154.062994177 g/mol
Topological Polar Surface Area60.7 Ų
Heavy Atom Count11
Formal Charge0
Complexity116
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Platelet Aggregation Inhibitors

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)


Anti-Infective Agents

Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)


Antioxidants

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty